The Pharmaceutical Research and Manufacturers of America recently submitted an amicus brief urging a federal court to dismiss a whistleblower’s False
Continue Reading PhRMA Submits Amicus Brief on First Amendment Issues
Mass Tort Defense
Defense of Mass Tort Claims, Class Actions, and Significant Product-Based Litigation